ASX:RAP

Email Alerts for:
ASX:RAP

ResApp Health (ASX:RAP) grants Sanofi an option to licence startup outcomes

15 Nov 2019 - Digital health company ResApp Health (ASX:RAP) has penned an agreement which grants Sanofi an exclusive license to use the outcomes generated under the Startup Creasp…

ResApp Health (ASX:RAP) to join Creasphere Digital Health Program

04 Oct 2019 - Digital health company, ResApp Health (ASX:RAP) has been selected to join the Startup Creasphere Digital Health Program in Munich.

NAB shares hit on fresh remediation charges: ASX tracking 1.3% lower at noon

02 Oct 2019 - The ASX opened lower following soft leads from Wall Street and is now tracking 1.3% lower at noon. The markets dropped on poor manufacturing results from the US and w…

Integral Diagnostics (ASX:IDX) appoints Dr Milne: Aus shares close 0.4% lower

30 Sep 2019 - It’s been a bearish afternoon on the Australian share market. The S&P/ASX 200 index closed 0.4% lower. UBS has downgraded Alumina (ASX:AWC) from a neutral to a sell, …

ResApp (ASX:RAP) flags positive results from prospective at-home sleep apnoea study

30 Sep 2019 - ResApp (ASX:RAP) has flagged top-line results from its prospective, blinded at-home obstructive sleep apnoea study.

ResApp Health receives CE Mark approval for Europe

26 Sep 2019 - ResApp Health (ASX:RAP) has received CE Mark approval for ResAppDx-EU version 2, the latest version of the world’s first smartphone-based diagnostic test for respirat…

RBA cut rates to historical low, banks under pressure: Aus shares close 0.1% higher

02 Jul 2019 - Australian share market falls after RBA cut rates as expected to 1%, but the ASX200 claws back into positive territory, rising for the 2nd session. Financials lost ov…

ResApp Health engages UK-based consultant

29 May 2019 - Digital health company ResApp Health (ASX:RAP) has engaged a UK-based medical device consultant to develop customised hardware and wearable devices capable of running…

ResApp share price skyrockets: ASX closes 1 per cent higher

23 Apr 2019 - It has been a positive day of trade for the ASX. After opening in the black the local bourse managed to maintain momentum to gain 1%. Appen (ASX:APX) share price surg…

Study shows ResApp Health algorithms deliver high accuracy

23 Apr 2019 - Digital health smartphone company for respiratory disease, ResApp Health (ASX:RAP) has announced positive top-line results from its Australian Breathe Easy adult clin…

ResApp Health (ASX:RAP) Presentation, FNN Investor Event, November 2018, Sydney

13 Dec 2018 - ResApp Health Limited (ASX:RAP) Managing Director and CEO Tony Keating provides an update on trial results, regulatory approval for the company's respiratory diagnosi…

ResApp Health (ASX:RAP) trials and commercialisation

13 Dec 2018 - ResApp Health Limited (ASX:RAP) Managing Director and CEO Tony Keating provides an update on trial results, regulatory approval for the company's respiratory diagnosi…

ResApp announces institutional raising

19 Sep 2018 - ResApp (ASX:RAP) has today announced its received firm commitments from institutional and sophisticated investors to raise $7.5 million.

GDP growth beats expectations: ASX rises 0.36 per cent

06 Jun 2018 - Australian shares opened stronger but struggled to hold gains. We saw a dip prior to the release of the latest GDP figures which were above expectation and the market…

Momentum continues on Monday: Aus shares 0.22% higher at noon

08 Jan 2018 - Momentum continues on Monday: Aus shares 0.22% higher at noon. ResApp Health Limited (ASX:RAP) announces it has enrolled the first patient in its SMARTCOUGH-C-2 study…

ResApp Health (ASX:RAP) Presentation, FNN Investor Event, September 2017, Sydney

18 Sep 2017 - ResApp Health (ASX:RAP) Executive Director Brian Leedman talks about its world's first digital diagnostic smartphone cough app trial results, time frame for FDA appro…

ResApp Health (ASX:RAP) talks study results and clinical trials

18 Sep 2017 - ResApp Health (ASX:RAP) Executive Director Brian Leedman talks about the company's trial results from its paediatric and adult programs, time frame for FDA approval a…

Back in the black: Aus shares 0.42% higher at noon

09 Aug 2017 - Back in the black: Aus shares 0.42% higher at noon. ResApp Health (ASX:RAP) shares have been sold off following the company’s latest update on its SMARTCOUGH- C Stud…

Negative territory: Aus shares close 0.49% lower

02 Aug 2017 - Negative territory: Aus shares close 0.49% lower. ResApp Health Limited (ASX:RAP) has been placed into voluntary suspension, pending the release of an announcement r…

Sluggish start: Aus shares 0.32% higher at noon

31 July 2017 - Sluggish start: Aus shares 0.32% higher at noon. IMF Bentham Limited (ASX:IMF) has announced that it will fund on a conditional basis claims of certain current and …

ResApp provides paediatric study results

22 Jun 2017 - ResApp Health Limited (ASX:RAP) says it has delivered excellent results in its Australian pediatric SmartCough C study.

In the black: Aus shares 0.52% higher at noon

19 June 2017 - In the black: Aus shares 0.52% higher at noon. Pilbara Minerals Limited (ASX:PLS) has announced it has successfully raised $80 million in a heavily oversubscribed p…

ResApp Health (ASX:RAP) Presentation, CEO Sessions Sydney

08 Mar 2017 - ResApp Health (ASX:RAP) Managing Director & CEO Tony Keating presents at the ASX CEO Sessions in Sydney.

ResApp Health (ASX:RAP) discusses revolutionary diagnostic app for respiratory disease

08 Mar 2017 - ResApp Health (ASX:RAP) Managing Director & CEO, Dr Tony Keating, discusses the path to commercialising its smartphone app which diagnoses respiratory diseases

Market backtrack: Aus shares 0.85% lower at noon

10 Jan 2016 - Market backtrack: Aus shares 0.85% lower at noon. Paladin Energy Limited (ASX:PDN) has entered into a proposal to restructure its balance sheet, which will subsequent…